Skip to main content
. 2022 Nov 8;9:955125. doi: 10.3389/fmed.2022.955125

Table 3.

Effect-size estimates of MRR and monocytes for mortality as categorical variable in the derivation cohort.

Parameters Case/Total Survival rate, % Unadjusted HR (95% CI) Adjusted HR (95% CI)
MRR
Reference group 100/168 22.57 Reference Reference
Risk group 53/80 12.93 1.40 (1.00–1.96) 1.56 (1.02–2.37)
Monocyte
Reference group 119/200 20.66 Reference Reference
Risk group 34/49 13.83 1.53 (1.04–2.24) 1.90 (1.16–3.11)

MRR, monocyte-to-red blood cell count ratio; HR, hazard ratio; 95% CI, 95% confidence interval. Effect-size estimates were calculated under the COX proportional hazard regression models.

Adjusted HR was adjusted for age, gender, FVC (% predicted), DLCO (% predicted), Charlson Comorbidity Index, and drug therapy (steroids, N-acetylcysteine). P was calculated by Kaplan–Meier analysis. Cutoff values: 0.13 for MRR, 0.67 for monocyte.